- Previous Rank
- Revenue 3 Yr Annual Growth Rate29
- Revenue 3 Yr Growth Rank46
- EPS 3 Yr Annual Growth Rate52
- EPS 3 Yr Growth Rank33
- Total Return 3 Yr Annual Rate61
- Total Return 3 Yr Rank5
Inogen is an oxygen device maker—which, on first glance, may not seem like the most riveting business. But the company’s return to shareholders and skyrocketing earnings growth are indisputable. In the second quarter of 2018, Inogen recorded revenues of more than $97 million—a nearly 52% year-over-year rise from the same period in 2017. The operating income growth will let the company engage in an aggressive hiring binge among its sales force, according to CEO Scott Wilkinson, and the stock is up nearly 95% year-to-date.
Company Information
| Location | Goleta, Calif. |
| Industry | Medical Products & Equipment |
| Sector | Health Care |
| Current Streak | - |
| Years on List | 1 |
| CEO | Scott Wilkinson |
| Website | www.inogen.com |
Revenue, Net Income
| Revenue past four quarters ($M) | $276 |
| Net Income past four quarters ($M) | $26 |
Growth Rates and Ranks
| Revenue 3 Yr Growth Rank | 46 |
| Revenue 3 Yr Annual Growth Rate | 29% |
| EPS 3 Yr Growth Rank | 33 |
| EPS 3 Yr Annual Growth Rate | 52% |
| Total Return 3 Yr Rank | 5 |
| Total Return 3 Yr Annual Rate | 61% |
| Beat S&P 500 (11.9%) | yes |
| P/E Ratio | 113 |